Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary
- 16 August 2007
- journal article
- Published by Wiley in Cancer Science
- Vol. 98 (10), 1586-1591
- https://doi.org/10.1111/j.1349-7006.2007.00582.x
Abstract
A monoclonal antibody (mAb) MY.1E12 was applied to detect MUC1 with sialylated glycans in a total of 55 formalin-fixed, paraffin-embedded surgical specimens of ovarian clear cell adenocarcinomas. A reverse correlation between the binding levels of this mAb and patient survival was demonstrated. To examine the role of MUC1 in ovarian clear cell carcinomas, two cDNA encoding MUC1 were transfected into ES-2 ovarian clear cell carcinoma cells. By comparing these cells, the role of MUC1 in tumorigenicity, chemosensitivity and survival under anoikis conditions were assessed. The results indicate that MUC1 expressed on ovarian clear cell carcinoma cells is causally involved in the malignant behavior.Keywords
This publication has 38 references indexed in Scilit:
- The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-CateninPublished by Elsevier BV ,2001
- A MUC1 Mucin Secreted from a Colon Carcinoma Cell Line Inhibits Target Cell Lysis by Natural Killer CellsCellular Immunology, 1997
- Effect of MUC1 Mucin, an Anti‐adhesion Molecule, on Tumor Cell GrowthJapanese Journal of Cancer Research, 1996
- A Novel Monoclonal Antibody Specific for Sialylated MUC1 MucinJapanese Journal of Cancer Research, 1996
- A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.Molecular Biology of the Cell, 1996
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- Establishment and Characterization of Two Human Ovarian Clear Cell Adenocarcinoma Lines from Metastatic Lesions with Different PropertiesGynecologic Oncology, 1995
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- Disruption of epithelial cell-matrix interactions induces apoptosisThe Journal of cell biology, 1994
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990